JGP Global Gestao de Recursos Ltda. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 9.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,172 shares of the healthcare conglomerate's stock after selling 326 shares during the period. UnitedHealth Group comprises 1.4% of JGP Global Gestao de Recursos Ltda.'s investment portfolio, making the stock its 10th biggest position. JGP Global Gestao de Recursos Ltda.'s holdings in UnitedHealth Group were worth $1,602,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. WealthShield Partners LLC lifted its stake in shares of UnitedHealth Group by 14.8% during the 3rd quarter. WealthShield Partners LLC now owns 5,000 shares of the healthcare conglomerate's stock valued at $2,525,000 after buying an additional 646 shares in the last quarter. Commerce Bank lifted its stake in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Commerce Bank now owns 120,737 shares of the healthcare conglomerate's stock valued at $60,976,000 after buying an additional 1,803 shares in the last quarter. Triad Financial Advisors Inc. lifted its stake in shares of UnitedHealth Group by 4.2% during the 3rd quarter. Triad Financial Advisors Inc. now owns 638 shares of the healthcare conglomerate's stock valued at $322,000 after buying an additional 26 shares in the last quarter. Briaud Financial Planning Inc lifted its stake in shares of UnitedHealth Group by 21.9% during the 3rd quarter. Briaud Financial Planning Inc now owns 568 shares of the healthcare conglomerate's stock valued at $313,000 after buying an additional 102 shares in the last quarter. Finally, XML Financial LLC lifted its stake in UnitedHealth Group by 20.2% in the 3rd quarter. XML Financial LLC now owns 2,716 shares of the healthcare conglomerate's stock worth $1,372,000 after purchasing an additional 456 shares in the last quarter. 86.31% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 450 shares of the firm's stock in a transaction dated Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total value of $244,035.00. Following the completion of the sale, the executive vice president now directly owns 8,736 shares of the company's stock, valued at approximately $4,737,532.80. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.40% of the company's stock.

UnitedHealth Group Price Performance

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion for the quarter, compared to analyst estimates of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. The company's revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned $4.48 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 24.9 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th were issued a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date was Friday, December 2nd. UnitedHealth Group's dividend payout ratio (DPR) is presently 31.15%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. SVB Leerink lowered their target price on shares of UnitedHealth Group from $625.00 to $618.00 and set an "outperform" rating on the stock in a research note on Monday, October 17th. Credit Suisse Group increased their target price on shares of UnitedHealth Group from $590.00 to $610.00 and gave the stock an "outperform" rating in a research note on Wednesday, December 7th. Morgan Stanley reiterated an "overweight" rating and issued a $587.00 target price on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $615.00 to $617.00 and gave the stock a "buy" rating in a report on Tuesday. Finally, Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to an "outperform" rating and set a $615.00 price target on the stock. in a report on Monday, November 21st. Three investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $599.39.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

• Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
• Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
• How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
• Is the Pain Over for Baudax Bio Investors after a 70% Spike?
• Will Rocket Lab's First U.S. Launch Send Stock Into Stratosphere?
• When Will Crane Holdings Take Flight?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.